MAPT and Alzheimer disease: Cellular component enrichments highlighted lipid metabolism pathways (HDL particle, protein-lipid complex, VLDL particle, TG-rich lipoprotein, phospholipid efflux), and molecular function analysis revealed tau binding — all established AD mechanisms.